Kawaoka Y - Search Results

1

Epitopes required for antibody-dependent enhancement of Ebola virus infection.

Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y. Takada A, et al. Among authors: kawaoka y. J Infect Dis. 2007 Nov 15;196 Suppl 2:S347-56. doi: 10.1086/520581. J Infect Dis. 2007. PMID: 17940970

2

Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.

Neumann G, Feldmann H, Watanabe S, Lukashevich I, Kawaoka Y. Neumann G, et al. Among authors: kawaoka y. J Virol. 2002 Jan;76(1):406-10. doi: 10.1128/jvi.76.1.406-410.2002. J Virol. 2002. PMID: 11739705 Free PMC article.

3

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y. Noda T, et al. Among authors: kawaoka y. J Virol. 2002 May;76(10):4855-65. doi: 10.1128/jvi.76.10.4855-4865.2002. J Virol. 2002. PMID: 11967302 Free PMC article.

4

Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses.

Takada A, Feldmann H, Stroeher U, Bray M, Watanabe S, Ito H, McGregor M, Kawaoka Y. Takada A, et al. Among authors: kawaoka y. J Virol. 2003 Jan;77(2):1069-74. doi: 10.1128/jvi.77.2.1069-1074.2003. J Virol. 2003. PMID: 12502822 Free PMC article.

5

Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test.

Ogino M, Ebihara H, Lee BH, Araki K, Lundkvist A, Kawaoka Y, Yoshimatsu K, Arikawa J. Ogino M, et al. Among authors: kawaoka y. Clin Diagn Lab Immunol. 2003 Jan;10(1):154-60. doi: 10.1128/cdli.10.1.154-160.2003. Clin Diagn Lab Immunol. 2003. PMID: 12522053 Free PMC article.

6

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

Takada A, Matsushita S, Ninomiya A, Kawaoka Y, Kida H. Takada A, et al. Among authors: kawaoka y. Vaccine. 2003 Jul 4;21(23):3212-8. doi: 10.1016/s0264-410x(03)00234-2. Vaccine. 2003. PMID: 12804850

7

Antibody-dependent enhancement of Ebola virus infection.

Takada A, Feldmann H, Ksiazek TG, Kawaoka Y. Takada A, et al. Among authors: kawaoka y. J Virol. 2003 Jul;77(13):7539-44. doi: 10.1128/jvi.77.13.7539-7544.2003. J Virol. 2003. PMID: 12805454 Free PMC article.

8

Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.

Horimoto T, Takada A, Iwatsuki-Horimoto K, Hatta M, Goto H, Kawaoka Y. Horimoto T, et al. Among authors: kawaoka y. J Virol. 2003 Jul;77(14):8031-8. doi: 10.1128/jvi.77.14.8031-8038.2003. J Virol. 2003. PMID: 12829842 Free PMC article.

9

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications.

Takada A, Kawaoka Y. Takada A, et al. Among authors: kawaoka y. Rev Med Virol. 2003 Nov-Dec;13(6):387-98. doi: 10.1002/rmv.405. Rev Med Virol. 2003. PMID: 14625886 Review.

10

Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.

Watanabe S, Watanabe T, Noda T, Takada A, Feldmann H, Jasenosky LD, Kawaoka Y. Watanabe S, et al. Among authors: kawaoka y. J Virol. 2004 Jan;78(2):999-1005. doi: 10.1128/jvi.78.2.999-1005.2004. J Virol. 2004. PMID: 14694131 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

969 results

Search Page

Filters